Moderna to Build its First African Vaccine Plant in Kenya Worth $500M -Massachusetts, US-based biotechnology and pharmaceuticals firm Moderna is set to build a manufacturing facility in Kenya to produce mRNA... -
Massachusetts, US-based biotechnology and pharmaceuticals firm Moderna is set to build a manufacturing facility in Kenya to produce mRNA vaccines, including those for COVID-19.
“We are pleased to partner with Moderna in the establishment of this mRNA manufacturing facility to help prepare the country and our sister states on the continent through the African Union to respond to future health crises and stave off the next pandemic,” Kenyan President Uhuru Kenyatta said after the deal was announced.
This latest announcement from Moderna comes amidst international pressure on major biotech firms like Moderna and Pfizer to share knowledge and expertise with manufacturers in countries that are disadvantaged when it comes to receiving COVID-19 vaccines, such as developing countries in Africa.